BioSpace News Archive

Xeris Biopharma Holdings, Inc. announced that the Company will release its first quarter 2024 financial results before the open of the U.S. financial markets on Thursday, May 9, 2024.

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable.

Bruker Corporation announced financial results for its first quarter ended March 31, 2024.

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported financial results for the quarter ended March 31, 2024.

Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

Delphia Therapeutics, Inc., announced its launch to pioneer a new area of cancer biology – activation lethality – which targets cancer’s surprising vulnerability to oncogene overactivation.

Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca’s CALQUENCE® in combination with standard-of-care chemoimmunotherapy, bendamustine and rituximab, demonstrated a statistically significant and clinically meaningful improvement in progression-free survival versus standard of care in previously untreated adult patients with mantle cell lymphoma.

Theralase® Technologies Inc. is pleased to announce that it has expanded its clinical team with the hiring of two Clinical Research Associates.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its first quarter 2024 financial results and other key updates from the quarter.

Alvotech announced today that members of management would be participating in the upcoming BofA Securities Healthcare Conference 2024, which will be held on May 14-15, 2024 in Las Vegas, NV.